Cases & Deals

Nanobiotix completes €25.1 million private placement of new shares

Clients Nanobiotix

Jones Day advised Nanobiotix, an oncology focused nanomedicine company listed on the regulated market of Euronext in Paris, in connection with its €25.1 million (US$26.5 million) private placement of new shares to U.S. and European investors.